Find a business

        More Info

        General Info
        Vigil will use the Series A funds to progress its lead pipeline candidate, a monoclonal antibody TREM2 agonist, through Phase 1 studies, advance their small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.
        Location
        One Broadway Bldg
        Other Link

        https://www.vigilneuro.com

        Category
        Research Services

        Reviews

        Hi there!
        Be the first to review!
        What do you rate this business?First-classBetter than mostAbout what I expectedNot the worst...Disappointing
        Click to Rate

        Details

        Phone: (857) 254-4445

        Address: 100 Forge Rd, Watertown, MA 02472

        Website: https://www.vigilneuro.com

        People Also Viewed